Health Care • Medical Specialities
$2.64 ▼ -0.34
(-11.41%)
MKT CAP: $4.4M • VOL: 26.2K
52W L $2 52W H $24
ROARABLE / RQD
E • 32/100
PIOTROSKI
1 / 9
ADVB // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 |
|---|---|---|
| Revenue (Total Sales) | $0 | $0 |
| YoY Revenue Growth % | — | — |
| Gross Profit | — | — |
| Gross Margin % | — | — |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$1.1M | $0 |
| Operating Margin % | — | — |
| Net Income (GAAP) | -$3.3M | -$2.8M |
| EBITDA (Normalized) | -$1.1M | — |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$5.8M | -$2.1M |
| Capital Expenditures (CapEx) | $31.6K | $74.1K |
| Free Cash Flow (FCF) | -$5.9M | -$2.2M |
| FCF Margin % | — | — |
| Return on Invested Capital (ROIC %) | -9.1% | — |
| Cash & Short-Term Equivalents | — | — |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | $9.5M | $619.0K |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ADVB.